生存率-话题@MedSci

#生存率#

482篇内容 | 3052人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1256805, encodeId=6618125680591, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Lancet Oncol：Ivosidenib显著改善晚期mIDH1胆管癌患者的生存率, objectType=article, longId=205802, objectId=07772058025d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07772058025d, replyNumber=0, likeNumber=0, createdTime=2021-01-18, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07772058025d, moduleTitle=Lancet Oncol：Ivosidenib显著改善晚期mIDH1胆管癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07772058025d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256804, encodeId=10d0125680422, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAHA：左心室心肌致密化不全患者的长期生存率, objectType=article, longId=205792, objectId=6cf4205e92c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cf4205e92c8, replyNumber=0, likeNumber=76, createdTime=2021-01-17, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cf4205e92c8, moduleTitle=JAHA：左心室心肌致密化不全患者的长期生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cf4205e92c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256803, encodeId=aaef125680343, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Gastroenterology:早期经颈静脉肝内门体静脉分流术对肝硬化伴有急性静脉曲张出血高危患者1年生存率的影响, objectType=article, longId=205637, objectId=29fc20563e27, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29fc20563e27, replyNumber=0, likeNumber=55, createdTime=2021-01-13, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29fc20563e27, moduleTitle=Gastroenterology:早期经颈静脉肝内门体静脉分流术对肝硬化伴有急性静脉曲张出血高危患者1年生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29fc20563e27)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256802, encodeId=82aa125680282, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Eur Radiol：肝癌累及了肝静脉或下腔静脉，经动脉化疗栓塞后总生存率怎么样？, objectType=article, longId=205353, objectId=2154205353fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2154205353fe, replyNumber=0, likeNumber=77, createdTime=2021-01-07, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2154205353fe, moduleTitle=Eur Radiol：肝癌累及了肝静脉或下腔静脉，经动脉化疗栓塞后总生存率怎么样？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2154205353fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256801, encodeId=7622125680133, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Gastroenterology：直接作用抗病毒药可改善肝细胞癌治疗后的生存率和复发率, objectType=article, longId=204611, objectId=829e2046114d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=829e2046114d, replyNumber=0, likeNumber=0, createdTime=2020-12-18, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=829e2046114d, moduleTitle=J Gastroenterology：直接作用抗病毒药可改善肝细胞癌治疗后的生存率和复发率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=829e2046114d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256800, encodeId=81171256800d0, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAHA：内脏静脉血栓形成与生存率的关联, objectType=article, longId=204226, objectId=a0be20422621, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0be20422621, replyNumber=0, likeNumber=69, createdTime=2020-12-08, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0be20422621, moduleTitle=JAHA：内脏静脉血栓形成与生存率的关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0be20422621)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256799, encodeId=0c1f1256e9972, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Hepatology：特利加压素可较去甲肾上腺素给予更好的改善ACLF患者的生存率, objectType=article, longId=204222, objectId=abb0204222a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abb0204222a7, replyNumber=0, likeNumber=82, createdTime=2020-12-08, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abb0204222a7, moduleTitle=Hepatology：特利加压素可较去甲肾上腺素给予更好的改善ACLF患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abb0204222a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256798, encodeId=373f1256e9803, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=BMJ Gastroenterology：食管切除术后体重严重减轻与食管癌患者5年生存率降低有关, objectType=article, longId=204209, objectId=335d20420980, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=335d20420980, replyNumber=0, likeNumber=76, createdTime=2020-12-08, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=335d20420980, moduleTitle=BMJ Gastroenterology：食管切除术后体重严重减轻与食管癌患者5年生存率降低有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=335d20420980)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256797, encodeId=fcbc1256e9798, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Gastroenterology: 肝硬化患者对托伐普坦的持久反应可提高无复发的长期生存率, objectType=article, longId=204151, objectId=d99f20415102, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d99f20415102, replyNumber=0, likeNumber=71, createdTime=2020-12-07, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d99f20415102, moduleTitle=J Gastroenterology: 肝硬化患者对托伐普坦的持久反应可提高无复发的长期生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d99f20415102)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256796, encodeId=4df21256e9623, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Brit J Cancer：二甲双胍与肺癌患者生存率的关系, objectType=article, longId=204050, objectId=203e20405015, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=203e20405015, replyNumber=0, likeNumber=64, createdTime=2020-12-04, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=203e20405015, moduleTitle=Brit J Cancer：二甲双胍与肺癌患者生存率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=203e20405015)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256795, encodeId=55ad1256e95bf, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Clin Nutrition:饮食不健康和久坐行为与癌症生存率有关。, objectType=article, longId=203431, objectId=2a5b20343187, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a5b20343187, replyNumber=0, likeNumber=82, createdTime=2020-11-17, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a5b20343187, moduleTitle=Clin Nutrition:饮食不健康和久坐行为与癌症生存率有关。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a5b20343187)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256794, encodeId=21ef1256e94b9, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=BTK抑制剂Calquence降低了COVID-19患者体内炎症，但未能改善生存率, objectType=article, longId=203337, objectId=625b20333ea4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=625b20333ea4, replyNumber=0, likeNumber=69, createdTime=2020-11-15, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=625b20333ea4, moduleTitle=BTK抑制剂Calquence降低了COVID-19患者体内炎症，但未能改善生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=625b20333ea4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256793, encodeId=17821256e93a3, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=诺华IL-1β单抗canakinumab治疗新冠COVID-19：未能提高生存率, objectType=article, longId=203185, objectId=8a9e203185f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a9e203185f0, replyNumber=0, likeNumber=83, createdTime=2020-11-11, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a9e203185f0, moduleTitle=诺华IL-1β单抗canakinumab治疗新冠COVID-19：未能提高生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a9e203185f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256792, encodeId=4f221256e927f, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Chest：间质性肺疾病患者抗凝治疗与生存率之间的关联, objectType=article, longId=202240, objectId=54b3202240f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54b3202240f6, replyNumber=0, likeNumber=103, createdTime=2020-10-19, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54b3202240f6, moduleTitle=Chest：间质性肺疾病患者抗凝治疗与生存率之间的关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54b3202240f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256791, encodeId=e2171256e91b9, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA Oncol ：咖啡又一功效！可改善结直肠癌晚期或转移性患者的生存率和恶化风险, objectType=article, longId=202110, objectId=cfcc20211089, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfcc20211089, replyNumber=0, likeNumber=88, createdTime=2020-10-16, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfcc20211089, moduleTitle=JAMA Oncol ：咖啡又一功效！可改善结直肠癌晚期或转移性患者的生存率和恶化风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfcc20211089)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256790, encodeId=d2a81256e903c, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=全球肝癌患者中，中国人占一半！4种治疗方式，可以提高生存率, objectType=article, longId=201700, objectId=3a54201e0068, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a54201e0068, replyNumber=0, likeNumber=57, createdTime=2020-10-07, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a54201e0068, moduleTitle=全球肝癌患者中，中国人占一半！4种治疗方式，可以提高生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a54201e0068)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256789, encodeId=94c31256e89d6, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Lancet：根治性手术后立即进行辅助放疗对前列腺癌患者无事件生存率的影响, objectType=article, longId=201390, objectId=f3e020139073, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3e020139073, replyNumber=0, likeNumber=63, createdTime=2020-10-01, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3e020139073, moduleTitle=Lancet：根治性手术后立即进行辅助放疗对前列腺癌患者无事件生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3e020139073)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256788, encodeId=ffb11256e8833, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Br J Cancer：III期临床试验：选择性淋巴结照射和或厄洛替尼联合放化疗改善局部晚期食道鳞状细胞癌患者长期生存率, objectType=article, longId=201182, objectId=099320118291, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=099320118291, replyNumber=0, likeNumber=20, createdTime=2020-09-26, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=099320118291, moduleTitle=Br J Cancer：III期临床试验：选择性淋巴结照射和或厄洛替尼联合放化疗改善局部晚期食道鳞状细胞癌患者长期生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=099320118291)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256787, encodeId=e1d81256e87d6, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Br J Cancer：免疫相关机制影响胃癌患者的生存率, objectType=article, longId=201139, objectId=a1a020113944, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1a020113944, replyNumber=0, likeNumber=74, createdTime=2020-09-25, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1a020113944, moduleTitle=Br J Cancer：免疫相关机制影响胃癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1a020113944)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256786, encodeId=9ff11256e865f, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Prostate Cancer P D：未治疗转移前列腺癌前期化疗的生存率研究 , objectType=article, longId=200820, objectId=9623200820cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9623200820cb, replyNumber=0, likeNumber=70, createdTime=2020-09-19, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9623200820cb, moduleTitle=Prostate Cancer P D：未治疗转移前列腺癌前期化疗的生存率研究 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9623200820cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存率

2020-05-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Lancet Oncol：Ivosidenib显著改善晚期mIDH1胆管癌患者的生存率

2021-01-18

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAHA：左心室心肌致密化不全患者的长期生存率

2021-01-17

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Gastroenterology:早期经颈静脉肝内门体静脉分流术对肝硬化伴有急性静脉曲张出血高危患者1年生存率的影响

2021-01-13

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Eur Radiol：肝癌累及了肝静脉或下腔静脉，经动脉化疗栓塞后总生存率怎么样？

2021-01-07

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Gastroenterology：直接作用抗病毒药可改善肝细胞癌治疗后的生存率和复发率

2020-12-18

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAHA：内脏静脉血栓形成与生存率的关联

2020-12-08

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Hepatology：特利加压素可较去甲肾上腺素给予更好的改善ACLF患者的生存率

2020-12-08

guoyibin (审核中...)

前往app查看评论内容

#生存率#

BMJ Gastroenterology：食管切除术后体重严重减轻与食管癌患者5年生存率降低有关

2020-12-08

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Gastroenterology: 肝硬化患者对托伐普坦的持久反应可提高无复发的长期生存率

2020-12-07

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Brit J Cancer：二甲双胍与肺癌患者生存率的关系

2020-12-04

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Clin Nutrition:饮食不健康和久坐行为与癌症生存率有关。

2020-11-17

guoyibin (审核中...)

前往app查看评论内容

#生存率#

BTK抑制剂Calquence降低了COVID-19患者体内炎症，但未能改善生存率

2020-11-15

guoyibin (审核中...)

前往app查看评论内容

#生存率#

诺华IL-1β单抗canakinumab治疗新冠COVID-19：未能提高生存率

2020-11-11

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Chest：间质性肺疾病患者抗凝治疗与生存率之间的关联

2020-10-19

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA Oncol ：咖啡又一功效！可改善结直肠癌晚期或转移性患者的生存率和恶化风险

2020-10-16

guoyibin (审核中...)

前往app查看评论内容

#生存率#

全球肝癌患者中，中国人占一半！4种治疗方式，可以提高生存率

2020-10-07

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Lancet：根治性手术后立即进行辅助放疗对前列腺癌患者无事件生存率的影响

2020-10-01

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Br J Cancer：III期临床试验：选择性淋巴结照射和或厄洛替尼联合放化疗改善局部晚期食道鳞状细胞癌患者长期生存率

2020-09-26

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Br J Cancer：免疫相关机制影响胃癌患者的生存率

2020-09-25

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Prostate Cancer P D：未治疗转移前列腺癌前期化疗的生存率研究

2020-09-19

科室
- - 订阅+
  - 更多科室
工具
服务